FMSNYSEServices-Misc Health & Allied Services, NECAlso trades as FMCQF

Fresenius Medical Care AG

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026

$21.94−0.23 (-1.04%)

Close on Oct 19, 2026

Market cap: $6.27B
P/E (TTM): –
Dividend yield: –

Fresenius Medical Care AG income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	–	–	–	–	–	–	–	–	–	–	–	5,265	4,970	–	–	–	–	–	–
Cost of Revenue	–	–	–	–	–	–	–	–	–	12,131	11,406	10,836	9,871	9,199	8,418	8,009	7,416	6,983	6,365
Gross Profit	–	–	–	–	–	–	–	–	–	5,780	5,331	4,996	4,738	4,601	4,152	3,835	3,832	3,629	3,356
Research & Development	–	–	–	–	–	–	–	–	–	162	140	122	126	112	111	97	94	80	67
Selling, General & Admin	–	–	–	–	–	–	–	–	–	3,045	2,896	2,644	2,383	2,225	2,002	1,824	1,987	1,876	1,709
Operating Income	–	–	–	–	–	–	–	–	–	2,638	2,327	2,255	2,256	2,219	2,075	1,924	1,756	1,672	1,580
Interest Expense	–	–	–	–	–	–	–	–	–	452	508	495	448	471	356	305	321	362	400
Interest & Investment Income	–	–	–	–	–	–	–	–	–	47	117	84	39	44	60	25	21	25	29
Income from Equity Investments	–	–	–	–	–	–	–	–	–	-65	-31	-25	-26	-17	-31	-8.95	4.53	–	–
Other Non-Operating Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	–	–	–	–	–	0.62	9.43	36	7.68	-5.89	1.25	24	-0.91
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	-2.32	-2.32	2.65	-33	-6.70	1.31	0.63	-1.31	-2.99	-2.70
Pretax Income	–	–	–	–	–	–	–	–	–	2,232	1,935	1,843	1,848	1,932	1,778	1,644	1,456	1,336	1,209
Income Tax Expense	–	–	–	–	–	–	–	–	–	683	622	584	592	605	601	578	490	476	454
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	1,549	1,313	1,260	1,256	1,327	1,177	1,065	965	860	755
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	306	284	215	146	140	106	87	74	42	38
Net Income	–	–	–	–	–	–	–	–	–	1,243	1,029	1,045	1,110	1,187	1,071	979	891	818	717
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	–	–	0.10	0.11	0.10	0.11	–	–
EPS (Basic)(per share)	–	–	–	–	–	–	–	–	–	4.07	3.38	3.46	3.65	3.89	3.54	3.25	2.99	2.75	2.43
EPS (Diluted)(per share)	–	–	–	–	–	–	–	–	–	4.06	3.38	3.45	3.65	3.87	3.51	3.24	2.99	2.74	2.42
Shares Outstanding (Basic, Weighted)(shares)	291	293	293	293	293	294	303	307	307	305,748	304	302	302	301	299	297	294	293	–
Shares Outstanding (Diluted, Weighted)(shares)	291	293	293	293	293	294	303	307	307	306	305	303	303	303	301	298	294	294	–
Dividend per Share(per share)	–	–	–	–	–	–	–	–	–	0.80	0.78	0.77	–	–	–	–	–	–	–
EBITDA	–	–	–	–	–	–	–	–	–	3,413	3,044	2,954	2,904	2,821	2,632	2,427	2,213	2,088	1,943
Net Interest Income	–	–	–	–	–	–	–	–	–	–	–	–	409	426	-297	-280	-300	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –